Related Experiment Video
Updated: May 6, 2026
Investigating Receptor-ligand Systems of the Cellulosome with AFM-based Single-molecule Force Spectroscopy
Published on: December 20, 2013
Atomic Force Microscopy Lifetime Analysis: An Intuitive Method for Evaluating Receptor Tyrosine Kinase
Qingqing Zou1, Qianqian Zhang1, Bin Du1
1State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha 410082, P. R. China.
A new atomic force microscopy method analyzes receptor tyrosine kinase dimers. This technique distinguishes between unliganded and liganded dimers, offering a novel approach for evaluating cancer metastasis inhibitors.
Area of Science:
- Biophysics
- Molecular Biology
- Cancer Research
Background:
- Receptor tyrosine kinases (RTKs) form unliganded and liganded dimers, crucial targets for inhibiting tumor metastasis.
- Current RTK dimer inhibitor analysis relies on endpoint assays, posing challenges in intuitive monitoring and distinguishing dimer types.
Purpose of the Study:
- To develop an intuitive, process-based method for evaluating mesenchymal-epithelial transition factor (MET) receptor inhibitors.
- To differentiate the inhibitory effects of compounds on unliganded versus liganded MET dimers at the single-molecule level.
Main Methods:
- Utilized atomic force microscopy (AFM) lifetime analysis to measure the stability of MET dimers.
- Defined bond lifetime as the time between force application and bond rupture to reflect dimer stability.
Main Results:
- Demonstrated significant differences in the lifetime of unliganded (207.87 ± 4.69 ms) and hepatocyte growth factor-induced liganded MET dimers (330.58 ± 15.60 ms).
- Showed aptamer SL1 inhibits both unliganded and liganded MET dimers by decreasing their lifetimes.
- Indicated heparin selectively inhibits liganded MET dimers by reducing their lifetime.
Conclusions:
- AFM-based lifetime analysis provides an intuitive, single-molecule method for evaluating RTK dimer status and inhibitors.
- This novel strategy offers a complementary approach for the research and development of RTK inhibitors, particularly for cancer therapy.
More Related Videos
14:09Fluorescence Biomembrane Force Probe: Concurrent Quantitation of Receptor-ligand Kinetics and Binding-induced Intracellular Signaling on a Single Cell
Published on: August 4, 2015
10:43Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis
Published on: November 6, 2019
